September 18, 2023

New publication from Pedro Lowenstein and Maria Castro's labs!

“Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial,” has been published in The Lancet Oncology.